GE Healthcare and DiA Analysis offer first-ever AI-powered ejection fraction app for a mobile ultrasound.
DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools, today announced that its LVivo EF cardiac decision-support software is now available for purchase for GE’s new Vscan Extend™ handheld, pocket-sized ultrasound.
Ejection fraction (EF) evaluation is a key diagnostic criterion driving various treatment strategies in point-of-care (POC) settings—particularly in emergency medicine, intensive care and anesthesia. The news of this partnership with GE Healthcare follows DiA’s closing of a $5 million funding round earlier this month.
The new software/hardware collaboration between DiA Imaging Analysis and GE Healthcare will bring cardiac ejection fraction evaluation to the bedside in point-of-care settings, including emergency medicine, intensive care and anesthesia. Ejection fraction analysis is an important diagnostic criterion in critical care situations. DiA’s app uses AI technology and advanced pattern recognition algorithms that imitate the way the human eye identifies borders and motion, which eliminates the subjectivity of visual estimation, which can vary in accuracy depending on clinician experience levels.
“As handheld, point-of-care ultrasound procedures expand across the industry, and AI plays a growing role in ultrasound analysis, working with GE Healthcare is the beginning of transforming point-of-care ultrasound to a more consistent and patient-centered process,” said DiA CEO and co-founder Hila Goldman-Aslan. “As the first automated EF software tool on a handheld ultrasound, we are confident that clinicians across emergency, primary care, ICU and other point-of-care settings will immediately recognize how LVivo EF empowers their real-time decision-making and enhances efficiency.”
Traditionally, most EF interpretation at POC is conducted through visual estimation, with clinician experience levels varying across POC settings. This means that achieving an accurate EF result in POC settings can be challenging. LVivo EF addresses this challenge by quickly and efficiently providing clinicians with left ventricle EF scoring and volume measurements via DiA ’s advanced, proprietary AI technology and advanced pattern recognition algorithms that imitate the way the human eye identifies borders and motion.
“Offering the LVivo EF app underscores GE Healthcare’s continued commitment to supporting clinicians with improved productivity,” said Rob Walton, general manager of GE Healthcare Primary Care Ultrasound. “By collaborating with third-party developers and experienced Vscan Extend users, GE Healthcare has been able to offer apps that give users the option to customize their Vscan Extend according to their unique needs.”
